Comparing the Fiscal Consequences of Controlled and Uncontrolled Osteoarthritis Pain Applying a UK Public Economic Perspective

Background: Individuals experiencing osteoarthritis (OA) pain can pose significant costs for governments due to reduced work activity in these individuals and increasing reliance on public support benefits. In this analysis we capture the broader economic impact of OA pain by applying a government perspective, public economic framework to assess controlled and uncontrolled pain. Methods: We used a Markov model to compare labour market participation in people with uncontrolled OA hip or knee pain compared to a cohort with controlled OA pain. The likelihood of employment, long-term sickness, disability, and early retirement in those with controlled pain used publicly available UK data. The relative effect of uncontrolled OA pain on fiscal outcomes is drawn from peer reviewed publications reporting reduced work activity and reliance on public benefits for people with uncontrolled OA pain. Lost tax revenue was derived using UK tax rates and national insurance contributions applied to annual earnings. Social benefit rules were applied to calculate government financial support to individuals. Health-care costs were calculated based on estimates from an UK observational study. The base case analysis compared the projected lost tax revenue and transfer payments for a 50-year-old cohort with severe OA pain, retiring at age 65. Results: For a 50-year-old individual with moderate uncontrolled OA pain with 15-years remaining work expectancy, the model estimated a £62 383 reduction in employment earnings, a £24 307 reduction in tax contributions and a need for £16 034 in government benefits, compared to a person with controlled OA pain. In people with severe uncontrolled OA pain incremental foregone earnings were estimated to be £126 384, £44 925 were not paid through taxation and £25 829 were received in public benefits, compared to the controlled pain cohort. Health-care costs represented 13% and 12% of all OA-related fiscal cost in the moderate uncontrolled OA pain and severe uncontrolled OA pain comparison, respectively. Conclusions: For governments, maintaining an active workforce is paramount to maintaining economic growth and reducing spending on government programs. The approach described here can be used to augment cost-effectiveness models to inform a range of stakeholders of benefits attributed to controlled OA pain.

[1]  Louise B. Russell,et al.  Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers , 2020, PharmacoEconomics.

[2]  M. Connolly,et al.  The fiscal consequences of public health investments in disease-modifying therapies for the treatment of multiple sclerosis in Sweden , 2020, Journal of medical economics.

[3]  G. Collins,et al.  Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017 , 2019, Annals of the Rheumatic Diseases.

[4]  M. Hannan,et al.  Osteoarthritis in England: Incidence Trends From National Health Service Hospital Episode Statistics , 2019, ACR open rheumatology.

[5]  A. Feigl,et al.  The short-term effect of BMI, alcohol use, and related chronic conditions on labour market outcomes: A time-lag panel analysis utilizing European SHARE dataset , 2019, PloS one.

[6]  Martin Hurst,et al.  The Green Book: Central Government Guidance on Appraisal and Evaluation , 2019 .

[7]  M. Thomas,et al.  Reasons why osteoarthritis predicts mortality: path analysis within a Cox proportional hazards model , 2018, RMD Open.

[8]  J. Branco,et al.  The impact of osteoarthritis on early exit from work: results from a population-based study , 2018, BMC Public Health.

[9]  A. Harris,et al.  Predictors of return-to-work in patients with chronic musculoskeletal pain: A randomized clinical trial. , 2018, Journal of rehabilitation medicine.

[10]  S. Breusch,et al.  Activity levels and return to work following total knee arthroplasty in patients under 65 years of age , 2017, The bone & joint journal.

[11]  J. Coast,et al.  Valuing productivity costs using the friction‐cost approach: Estimating friction‐period estimates by occupational classifications for the UK , 2017, Health economics.

[12]  M. Postma,et al.  The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care: A Government Perspective Analytic Framework. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[13]  Agnes Norris Keiller,et al.  A survey of the UK benefit system , 2016 .

[14]  F Guillemin,et al.  Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies. , 2016, Osteoarthritis and cartilage.

[15]  F. Rannou,et al.  Risk factors and burden of osteoarthritis. , 2016, Annals of physical and rehabilitation medicine.

[16]  R. Wolterbeek,et al.  Determinants of return to work 12 months after total hip and knee arthroplasty. , 2016, Annals of the Royal College of Surgeons of England.

[17]  D. Marshall,et al.  Risk of work loss due to illness or disability in patients with osteoarthritis: a population-based cohort study. , 2016, Rheumatology.

[18]  S. Dopson,et al.  The limitations of QALY: a literature review , 2016 .

[19]  R. Shrestha,et al.  Measuring labour productivity and the benefits of interventions for osteoarthritis: Project report for Medicines Australia , 2016 .

[20]  Jaume Puig-Junoy,et al.  Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies. , 2015, Seminars in arthritis and rheumatism.

[21]  F. Haddad,et al.  Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service? , 2015, The bone & joint journal.

[22]  K. Allen,et al.  Epidemiology of osteoarthritis: state of the evidence , 2015 .

[23]  D. Deehan,et al.  Understanding the patient-reported factors determining time taken to return to work after hip and knee arthroplasty , 2015, Knee Surgery, Sports Traumatology, Arthroscopy.

[24]  G. Pransky,et al.  Anticipated significant work limitation in primary care consulters with osteoarthritis: a prospective cohort study , 2014, BMJ Open.

[25]  Deborah Schofield,et al.  The individual and socioeconomic impact of osteoarthritis , 2014, Nature Reviews Rheumatology.

[26]  S. Kingsbury,et al.  Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. , 2014, Rheumatology.

[27]  Blair H. Smith,et al.  A study of National Health Service management of chronic osteoarthritis and low back pain , 2014, Primary Health Care Research & Development.

[28]  G. Hawker,et al.  All-Cause Mortality and Serious Cardiovascular Events in People with Hip and Knee Osteoarthritis: A Population Based Cohort Study , 2014, PloS one.

[29]  Philippe Ravaud,et al.  The Burden of Musculoskeletal Conditions , 2014, PloS one.

[30]  I. Ackerman,et al.  Comparison of Health-Related Quality of Life, Work Status, and Health Care Utilization and Costs According to Hip and Knee Joint Disease Severity: A National Australian Study , 2013, Physical Therapy.

[31]  M. Englund,et al.  Risk of sick leave and disability pension in working-age women and men with knee osteoarthritis , 2012, Annals of the rheumatic diseases.

[32]  A. Davis,et al.  Return to work and workplace activity limitations following total hip or knee replacement. , 2012, Osteoarthritis and cartilage.

[33]  J. Caro,et al.  Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  J. Kärrholm,et al.  Costs related to hip disease in patients eligible for total hip arthroplasty. , 2012, The Journal of arthroplasty.

[35]  C. Cooper,et al.  The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. , 2012, Osteoarthritis and cartilage.

[36]  F. Haddad,et al.  A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. , 2012, The Journal of bone and joint surgery. British volume.

[37]  R. Shrestha,et al.  Economic impacts of illness in older workers: quantifying the impact of illness on income, tax revenue and government spending , 2011, BMC public health.

[38]  S. Reichenbach,et al.  All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study , 2011, BMJ : British Medical Journal.

[39]  R. Shrestha,et al.  Early retirement and the financial assets of individuals with back problems , 2011, European Spine Journal.

[40]  J. Cappelleri,et al.  Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity , 2010, Arthritis research & therapy.

[41]  W. B. van den Hout,et al.  The value of productivity: human-capital versus friction-cost method , 2009, Annals of the Rheumatic Diseases.

[42]  M. Aalabaf-Sabaghi Decision modelling for health economic evaluation , 2007, Journal of Epidemiology and Community Health.

[43]  J. Véron,et al.  Ages, generations and the social contract : the demographic challenges facing the welfare state , 2007 .

[44]  D. Quinton,et al.  Unit Costs of Health and Social Care 2004 , 2004 .

[45]  Ronald Lee Demographic Change, Welfare, and Intergenerational Transfers: A Global Overview , 2003 .

[46]  R. Cardarelli,et al.  Generational Accounting in the UK , 2000 .

[47]  E M Badley,et al.  Differences between men and women in the rate of use of hip and knee arthroplasty. , 2000, The New England journal of medicine.

[48]  Laurence J. Kotlikoff,et al.  Generational Accounting: A Meaningful Way to Evaluate Fiscal Policy , 1994 .